Increment Antimicrobial Resistance During the COVID-19 Pandemic: Results from the Invifar Network.

Aim: This study aims to assess the changes in antimicrobial resistance among some critical and high-priority microorganisms collected previously and during the coronavirus disease 2019 (COVID-19) pandemic in Mexico. Methods: We collected antimicrobial susceptibility data for critical and high-priority microorganisms from blood, urine, respiratory samples, and from all specimens, in which the pathogen may be considered a causative agent. Data were stratified and compared for two periods: 2019 versus 2020 and second semester 2019 (prepandemic) versus the second semester 2020 (pandemic). Results: In the analysis of second semester 2019 versus the second semester 2020, in blood samples, increased resistance to oxacillin (15.2% vs. 36.9%), erythromycin (25.7% vs. 42.8%), and clindamycin (24.8% vs. 43.3%) (p ≤ 0.01) was detected for Staphylococcus aureus, to imipenem (13% vs. 23.4%) and meropenem (11.2% vs. 21.4) (p ≤ 0.01), for Klebsiella pneumoniae. In all specimens, increased ampicillin and tetracycline resistance was detected for Enterococcus faecium (p ≤ 0.01). In cefepime, meropenem, levofloxacin, and gentamicin (p ≤ 0.01), resistance was detected for Escherichia coli; and in piperacillin-tazobactam, cefepime, imipenem, meropenem, ciprofloxacin, levofloxacin, and gentamicin (p ≤ 0.01), resistance was detected for Pseudomonas aeruginosa. Conclusion: Antimicrobial resistance increased in Mexico during the COVID-19 pandemic. The increase in oxacillin resistance for S. aureus and carbapenem resistance for K. pneumoniae recovered from blood specimens deserves special attention. In addition, an increase in erythromycin resistance in S. aureus was detected, which may be associated with high azithromycin use. In general, for Acinetobacter baumannii and P. aeruginosa, increasing resistance rates were detected.

[Yeast susceptibility isolated from blood cultures of patients at the National Cardiology Institute Ignacio Chávez]. / Susceptibilidad de levaduras aisladas de hemocultivos en pacientes del Instituto Nacional de Cardiología Ignacio Chávez.

INTRODUCTION: With the increasing prevalence of bloodstream infections caused by Candida sp. is necessary to establish the susceptibility of resistant strains in various geographical regions. OBJECTIVE: To determine the in vitro susceptibility to fluconazole, itraconazole, voriconazole and amphotericin B in yeasts isolated from blood through E test method. MATERIAL AND METHODS: In the period from 1992 to 2007, a total 112 strains of Candida species were isolated from blood of patients at the National Institute of Cardiology Ignacio Chavez. Susceptibility of these strains was performed to know the level of resistance to Itraconazole, Fluconazole, Voriconazole and Amphotericine B by E test method. RESULTS: C. albicans was the most common species (60.2%), followed by C. tropicalis (9.8%). A five percent of resistance to itraconazole, 1.8% to fluconazole; and 0.9% to amphotericine B and voriconazole were found. C. glabrata was the most resistant species to the four antifungal agents. CONCLUSION: The yeasts resistance to the four antifungal agents is still lower in our patients.